CD163 and lung adenocarcinoma: In our study, we demonstrated a statistically significant correlation between PD-L1 expression of the tumoral cells and CD163-positive macrophages, supporting the complex protumoral interactions in lung adenocarcinomas, by harnessing the immune suppression potential of M2 macrophages (CD163+) and tumor immune evasion mechanisms.